Category: by subject

University investigating leading German derm lab that retracted Immunology paper

The laboratory of Michael Hertl, a German dermatology researcher with an international reputation, is under investigation for possible misconduct, according to a legal official at Hertl’s institution, Philipps-Universitat Marburg.

The acknowledgement was prompted by our query earlier this week about a 2008 paper from Hertl’s group that had been retracted by the journal Immunology. According to the July 25 retraction notice: Continue reading University investigating leading German derm lab that retracted Immunology paper

Physics paper retracted “on ethical grounds” — aka the data had already been published

There was a curious retraction published online last month in Physica Scripta, an Institute of Physics journal. The notice, for “Response of Cu 0.5 (Tl 0.5-y Hg y)Ba 2 Ca 3 Zn 2 Cu 2 O 12-δ (y =0, 0.15, 0.25 and 0.35) superconductors in electric and magnetic fields,” reads as follows: Continue reading Physics paper retracted “on ethical grounds” — aka the data had already been published

Why do — and don’t — journal editors retract articles?

Liz Wager, the chair of the Committee on Publication Ethics, knows something about retractions. In April, she and University College London’s Peter Williams published a paper in the Journal of Medical Ethics showing that journal editors’ approaches to retractions aren’t uniform.

The pair is back with another paper, using the same dataset of retractions and published in Science and Engineering Ethics, in which they ask journal editors why they retract — or don’t. The findings — more on them below — informed COPE’s 2009 guidelines on retractions, as did those in the April paper.

From the introduction to the new paper (link added): Continue reading Why do — and don’t — journal editors retract articles?

Should we change our name to Mori Watch? Yet another retraction from cancer researcher

Earlier this week we reported on the latest retraction of an article by Naoki Mori, number 21 in a series. We could have waited a few days and saved ourselves some trouble.

The journal Leukemia Research has retracted a 2006 paper by Mori, titled “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.” From the notice, which is behind a paywall: Continue reading Should we change our name to Mori Watch? Yet another retraction from cancer researcher

Sebastiani group retracts genetics of aging study from Science

When a group of researchers last year claimed to have found a “genetic signature” to identify people likely to live to 100, they were questioned immediately. Now they’ve retracted the controversial paper —  but continue to stand behind their assertion.

The paper had been the subject of an “Expression of Concern” in November. The retraction notice in this week’s Science: Continue reading Sebastiani group retracts genetics of aging study from Science

Another for Mori: 1999 Infection and Immunity paper pulled

When we first wrote about Naoki Mori last December, one question we had was why Infection and Immunity, the journal that got the ball rolling in this case, wasn’t retracting a 1999 article by the serial manipulator. Well, it has.

The August issue of the journal, a publication of the American Society of Microbiology — which levied a 10-year ban on Mori for his misdeeds — contains the following retraction notice: Continue reading Another for Mori: 1999 Infection and Immunity paper pulled

Marc Hauser resigns from Harvard

Marc Hauser, the Harvard psychology professor who retracted a paper last year following a university investigation, has resigned his post. As the Boston Globe’s Carolyn Johnson, who broke the original Hauser retraction story, reports: Continue reading Marc Hauser resigns from Harvard

Cryptic “legal issues” lead to retraction of paper about potential Novartis alcohol abuse drug

Readers of this blog by now know that if there’s one thing that really gets us going, it’s obfuscation. So it shouldn’t be surprising that the following retraction notice from the journal Psychopharmacology, made us particularly batty:

This paper has been retracted by the author because of legal issues.

The notice refers to  “Selective activation of the metabotropic glutamate receptor subtype 7 “mGluR7” attenuates acquisition, expression, and reinstatement of ethanol place preference,” was published online in late June by Amine Bahi under the heading “Original Investigation.”

Bahi is in the department of anatomy at United Arab Emirates University. He has also held positions at Yale and the University of Fribourg in Switzerland. Among his publications is one that involved a collaborator from Novartis (more on that in a moment). Continue reading Cryptic “legal issues” lead to retraction of paper about potential Novartis alcohol abuse drug

University of Louisville investigating work by team under review at Emory

On Tuesday, we reported that Emory University in Atlanta was looking into why a team of former researchers — now at the University of Louisville — had retracted three papers in the Journal of Biological Chemistry (JBC).

Today, we learned that the researchers’ home institution since 2009 is now investigating the work. A spokesperson tells Retraction Watch: Continue reading University of Louisville investigating work by team under review at Emory

German paper on inflammation taken out of Circulation (Research) for data manipulation

Circulation Research, a journal of the American Heart Association (AHA), has retracted a 2009 article from a German group whose first author copped to manipulating data — and got called on it. From the notice: Continue reading German paper on inflammation taken out of Circulation (Research) for data manipulation